Compare · CAH vs MCK
CAH vs MCK
Side-by-side comparison of Cardinal Health Inc. (CAH) and McKesson Corporation (MCK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CAH and MCK operate in Other Pharmaceuticals (Health Care), so they compete in similar markets.
- MCK is the larger of the two at $104.74B, about 1.9x CAH ($55.66B).
- Over the past year, CAH is up 54.1% and MCK is up 30.7% - CAH leads by 23.4 points.
- MCK has been more active in the news (15 items in the past 4 weeks vs 11 for CAH).
- Both have 25 recent analyst ratings on file.
- Company
- Cardinal Health Inc.
- McKesson Corporation
- Price
- $236.40-0.51%
- $869.27-0.17%
- Market cap
- $55.66B
- $104.74B
- 1M return
- +1.16%
- +9.62%
- 1Y return
- +54.10%
- +30.68%
- Industry
- Other Pharmaceuticals
- Other Pharmaceuticals
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 11
- 15
- Recent ratings
- 25
- 25
Cardinal Health Inc.
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.
McKesson Corporation
McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment offers CoverMyMeds solution to help patients get the medications; RelayHealth, a workflow solution; RxCrossroads solution for therapies and interventions to biopharma manufacturers; and McKesson Prescription Automation, a customized pharmacy automation technology; and Multi-Client Central Fill as a Service, a pharmacy. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Latest CAH
- Chief Executive Officer Hollar Jason M. was granted 187,965 shares, increasing direct ownership by 94% to 387,965 units (SEC Form 4)
- Chief Information Officer Greene Michelle D. was granted 17,230 shares, increasing direct ownership by 141% to 29,460 units (SEC Form 4)
- Chief Financial Officer Alt Aaron E was granted 58,738 shares, increasing direct ownership by 222% to 85,146 units (SEC Form 4)
- CEO, PSS Segment Weitzman Deborah was granted 54,823 shares, increasing direct ownership by 104% to 107,700 units (SEC Form 4)
- CEO, GMPD Segment Mason Stephen M was granted 46,992 shares, increasing direct ownership by 184% to 72,482 units (SEC Form 4)
- Chief Legal/Compliance Officer Mayer Jessica L was granted 46,992 shares, increasing direct ownership by 136% to 81,419 units (SEC Form 4)
- Chief Accounting Officer Scherer Mary C. was granted 2,610 shares, increasing direct ownership by 75% to 6,105 units (SEC Form 4)
- Chief Human Resources Officer Pitteroff Valerie Christine was granted 2,610 shares, increasing direct ownership by 33% to 10,632 units (SEC Form 4)
- Cardinal Health Inc. filed SEC Form 8-K: Leadership Update
- Cardinal Health expands home care business with two tuck-in acquisitions
Latest MCK
- SEC Form 10-Q filed by McKesson Corporation
- McKesson Reports Fiscal 2027 First Quarter Results and Raises Full Year Adjusted EPS Guidance
- McKesson Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- McKesson Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form 4 filed by Director Hinton James H.
- SEC Form 4 filed by Director Doughtie Lynne M
- Director Wilson-Thompson Kathleen was granted 277 shares, increasing direct ownership by 92% to 578 units (SEC Form 4)
- SEC Form 4 filed by Director Dunbar Webster Roy
- Director Caruso Dominic J was granted 277 shares, increasing direct ownership by 43% to 927 units (SEC Form 4)
- SEC Form 4 filed by Director Gerberding Julie L.